Related Experiment Video
Updated: Jun 24, 2026
11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Prognostic implication of p27 expression in primary central nervous system lymphoma
Katsuzo Kunishio1, Seigo Nagao
1Department of Neurosurgical Surgery, Kagawa University, Kagawa, Japan. k.kunisho@kawasaki-hp.jp
Brain Tumor Pathology
|December 21, 2007
Summary
p27/Kip1 (p27) expression predicts prognosis in primary central nervous system lymphomas (PCNSLs). High p27 levels indicate a poorer outlook for PCNSL patients, suggesting its utility as a prognostic marker.
Area of Science:
- Oncology
- Neuro-oncology
- Cell Biology
Background:
- Primary central nervous system lymphomas (PCNSLs) are rare aggressive non-Hodgkin lymphomas.
- The prognostic factors for PCNSL patients require further elucidation.
Purpose of the Study:
- To investigate the role of p27/Kip1 (p27) expression in PCNSLs.
- To correlate p27 expression with tumor proliferation and patient prognosis.
Main Methods:
- Immunohistochemical analysis of p27 expression in 22 PCNSL patient samples.
- Correlation of p27 expression levels with MIB-1 labeling index (proliferation) and overall survival.
Main Results:
- Tumors with low p27 expression showed a trend towards lower MIB-1 labeling index, but this difference was not statistically significant.
- High p27 expression was significantly associated with a poorer overall prognosis in PCNSL patients (P = 0.0011).
- MIB-1 labeling index did not show a significant association with prognosis.
Conclusions:
- p27 expression is a significant predictor of prognosis in patients with PCNSL.
- p27 may serve as a valuable prognostic biomarker for PCNSL management.
